Showing results (171-180 of 1,917) with videos related to
Sort By:
Pageof 192
CNS & Neurological Disorders Drug Targets|January 29, 2021
Withdrawal Notice: Comparison of Pharmaceutical Effect of Alemtuzumab and Natalizumab and Their Side Effects in Treatment of Various Stages of Multiple Sclerosis PatientsMostafa MohammadiCNS & Neurological Disorders Drug Targets|October 4, 2019
Role of Neuroimaging Modality in the Assessment of Oxidative Stress in Brain: A Comprehensive ReviewVikas Pareek, Banshi Nath, Prasun K RoyCNS & Neurological Disorders Drug Targets|August 11, 2019
Aberrant DNA Methylation Pattern may Enhance Susceptibility to Migraine: A Novel PerspectiveDivya Goel, Kaiser Un Nisa, Mohammad Irshad Reza, et al.CNS & Neurological Disorders Drug Targets|February 3, 2021
Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial DysfunctionUrja Kanojia, Shrikant Gyaneshwar Chaturbhuj, Runali Sankhe, et al.CNS & Neurological Disorders Drug Targets|March 3, 2021
Conifer Essential Oils Reversed Amyloid Beta1-42 Action by Modulating BDNF and ARC Expression in The Rat HippocampusPaula Alexandra Postu, Adrian Tiron, Crina Elena Tiron, et al.CNS & Neurological Disorders Drug Targets|January 14, 2011
Antioxidants in health, disease and agingMark E Obrenovich, Yi Li, Kalpana Parvathaneni, et al.CNS & Neurological Disorders Drug Targets|February 4, 2011
Hemichannels in the neurovascular unit and white matter under normal and inflamed conditionsJuan A Orellana, Xavier F Figueroa, Helmuth A Sánchez, et al.CNS & Neurological Disorders Drug Targets|August 19, 2007
Pathophysiology of tension-type headache: potential drug targetsMessoud AshinaCNS & Neurological Disorders Drug Targets|November 11, 2008
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseasesG De Vivo, V GentileCNS & Neurological Disorders Drug Targets|January 11, 2012
Immunotherapy for drug abuseXiaoyun Shen, Thomas R KostenPageof 192